结直肠癌肝转移瘤局部介入治疗应用进展

doi:10.11904/j.issn.1002-3070.2020.01.015

摘要/Abstract

摘要： 结直肠癌是世界上死亡率排名前5位的恶性肿瘤,其主要死因是肝转移。结直肠癌发生肝转移多是晚期,其治疗效果较差,生存期较短,严重影响结直肠癌的预后。目前,根治性手术切除是结直肠癌肝转移(Colorectal liver metastasis,CRLM)的一线治疗方法,然而,绝大多数病人在被确诊时已失去手术治疗的机会。国家综合癌症网络(National Comprehensive Cancer Network,NCCN)建议将局部治疗(Locoregional therapy,LRT)用于无法行根治性手术切除且对化疗不敏感或无效的CRLM患者,它主要包括经导管动脉内治疗和消融治疗。本文就局部介入治疗CRLM的应用进展做一综述。

关键词: 结直肠癌肝转移, 经导管动脉内治疗, 消融治疗

Abstract: Colorectal cancer is the top 5 malignant tumors in the world,and the main cause of death is liver metastasis.The liver metastasis of colorectal cancer is mostly advanced,its therapeutic effect is poor,and the survival time of patients is short,which seriously affects the prognosis of colorectal cancer patients.Radical surgical resection is currently the first-line treatment for colorectal liver metastasis(CRLM).However,the vast majority of patients have lost the opportunity to undergo surgery when they are diagnosed.The National Comprehensive Cancer Network(NCCN) recommends the use of locoregional therapy(LRT) for CRLM patients who are unable to undergo radical surgery and are insensitive or ineffective for chemotherapy,including transcatheter arterial therapy and ablation therapy.This article reviews the application progress of locoregional therapy for CRLM.

Key words: Colorectal cancer liver metastasis, Transcatheter arterial treatment, Ablation therapy

中图分类号:

R735.7

张景岚, 刘瑞宝. 结直肠癌肝转移瘤局部介入治疗应用进展[J]. 实用肿瘤学杂志, 2020, 34(1): 79-82.

ZHANG Jinglan, LIU Ruibao. Progress in local interventional therapy for colorectal cancer with liver metastasis[J]. Journal of Practical Oncology, 2020, 34(1): 79-82.

参考文献

1 Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
2 Chen WQ,Zheng RS,Peter D,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
3 Valderrama-Treviño AI,Barrera-Mera B,Ceballos-Villalva JC,et al.Hepatic metastasis from colorectal cancer[J].Hepato-Gastroenterol,2017,7(2):166-175.
4 中华医学会外科学分会胃肠外科学组,中华医学会外科学分会结直肠肛门外科学组,中国抗癌协会大肠癌专业委员会,等.结直肠癌肝转移诊断和综合治疗指南(2016版)[J].中华消化外科杂志,2016,15(8):755-779.
5 Gómez Dorronsoro ML,Vera R,Ortega L,et al.Recommendations of a group of experts for the pathological assessment of tumour regression of liver metastases of colorectal cancer and damage of non-tumour liver tissue after neoadjuvant therapy[J].Clin Transl Oncol,2014,16(3):234-242.
6 茅锐,张业繁,陈晓,等.肝动脉灌注化疗在结直肠癌肝转移术后辅助治疗中的应用[J].肝癌电子杂志,2017,4(2):21-23.
7 Kallini JR,Gabr A,Abouchaleh N,et al.New developmentsin interventional oncology:liver metastases from colorectal cancer[J].Cancer J,2016,22(6):373-380.
8 Arai Y,Aoyama T,Inaba Y,et al.Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer(JFMC28 study)[J].Asia Pac J Clin Oncol,2015,11(1):41-48.
9 Liu W,Song QK,Xing BC.A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases[J].Int J Colorectal Dis,2015,30(8):1091-1102.
10 简乾洪,郑方荣,阎雄.经肝动脉化疗栓塞术治疗结直肠癌肝转移的研究进展[J].临床肝胆病杂志,2016,32(6):1216-1219.
11 刘瑞宝,张景澜.cTACE规范化操作[J].肝癌电子杂志,2018,5(1):4-7.
12 钱杨,王健,曾昭冲.结直肠癌肝转移的治疗进展[J].中华结直肠疾病电子杂志,2016,5(1):16-20.
13 Gruber-Rouh T,Naguib NN,Eichler K,et al.Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer:long-term results over a 10-year period[J].Int J Cancer,2014,134(5):1225-1231.
14 Vogl TJ,Gruber T,Balzer JO,et al.Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer:prospective study[J].Radiology,2009,250(1):281-289.
15 Xing M,Kooby DA,El-Rayes BF,et al.Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review[J].J Surg Oncol,2014,110(2):182-196.
16 徐新建,滕飞,杜洪涛.伊立替康载药微球治疗结肠癌肝转移瘤的系统评价[J].中华介入放射学电子杂志,2017,5(4):273-281.
17 李莉,冯对平,李思进.经肝动脉90Y放射性栓塞治疗的新进展[J].中华核医学与分子影像杂志,2018,38(8):573-581.
18 Garin E,Rolland Y,Edeline J,et al.Personalized dosimetry and intensification concept with 90Y-loaded glass microsphere radioembolization induce prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis[J].J Nucl Med,2015,56(3):339-346.
19 Kennedy A,Brown DB,Feilchenfeldt J,et al.Safety of selective internal radiation therapy(SIRT) with yttrium-90 microspheres combined with systemic anticancer agents:expert consensus[J].Gastrointest Oncol,2017,8(6):1079-1099.
20 Hickey R,Lewandowski RJ,Prudhomme T,et al.90Y radioembolization of colorectal hepatic metastases using glass microspheres:safety and survival outcomes from a 531-patient multicenter study[J].J Nucl Med,2016,57(5):665-671.
21 Van Hazel GA,Heinemann V,Sharma NK,et al.SIRFLOX:Randomized phase III trial comparing first-line mFOLFOX6(Plus or Minus Bevacizumab) versus mFOLFOX6(Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer[J].J Clin Oncol,2016,34(15):1723-1731.
22 Gruber-Rouh T,Marko C,Thalhammer A,et al.Current strategies in interventional oncology of colorectal liver metastases[J].Br J Radiol,2016,89:20151060.
23 鲁立峰,盛勤松,邹德胜,等.结直肠癌切除联合射频消融对同时性结直肠癌肝转移临床指标、安全性及预后的影响[J].中华全科医学,2018,16(5):736-739.
24 陈海辉,冯成军,黄海欣.射频消融和放射治疗在结直肠癌肝转移局部治疗中的应用进展[J].广西医学,2018,40(3):326-329.
25 Ruers T,Van Coevorden F,Punt CJ,et al.Local treatment of unresectable colorectal liver metastases:results of a randomized phase II trial[J].J Natl Cancer Inst,2017,109(9):1-10.
26 Meijerink MR,Puijk RS,van Tilborg AA,et al.Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases:a systematic review and meta analysis[J].Cardiovasc Intervent Radiol,2018,41(8):1189-1204.
27 Tsitskari M,Filippiadis D,Kostantos C,et al.The role of interventional oncology in the treatment of colorectal cancer liver metastases[J].Ann Gastroenterol,2019,32(2):147-155.
28 Gurusamy K,Corrigan N,Croft J,et al.Liver resection surgery versus thermal ablation for colorectal LiVer MetAstases(LAVA):study protocol for a randomised controlled trial[J].Trials,2018,19(1):105.
29 周福波,于晓玲,梁萍,等.热消融治疗在结直肠癌肝转移中的应用进展[J].解放军医学院学报,2017,38(3):259-262.
30 Groeschl RT,Pilgrim CH,Hanna EM,et al.Microwave ablation for hepatic malignancies:a multiinstitutional analysis[J].Ann Surg,2014,259(6):1195-1200.
31 Petre EN,Sofocleous C.Thermal ablation in the management of colorectal cancer patients with oligometastatic liver disease[J].Visc Med,2017,33:62-68.

[1]	张文宝;张献南;朱献忠;傅国良;张小坚;朱金燕. 动脉化疗栓塞联合消融治疗肝转移瘤疗效分析[J]. 实用肿瘤学杂志, 2008, 22(02): 118-119,.
[2]	张钧;赵芳;高秀娟. 超声造影在肝癌消融治疗中的应用价值[J]. 实用肿瘤学杂志, 2006, 20(01): 51-52.
[3]	黄韵红;文小平;王文玲;周石;张凤莉;严国艳. 氩氦刀靶向冷冻治疗肝癌的初步研究[J]. 实用肿瘤学杂志, 2003, 17(03): 231-233.